在专业的COPD临床计划中,激发性流量和吸入器处方策略的峰值:现实世界的观察性研究
Sarah Pankovitch1, Michael Frohlich2, Bader AlOthman1
1Montreal Chest Institute, McGill University Health Centre, Montreal, QC, Canada.
Chest
|October 9, 2024
概括
许多COPD患者具有低于最佳的峰值吸气流 (PIF),并使用不合适的吸入器设备. 识别女性性别和低BMI等风险因素可以改善吸入器选择和患者的结果.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 对于COPD患者来说,最佳的吸入器选择至关重要,与他们的峰值吸入流 (PIF) 和设备类型保持一致.
- 当前的治疗方案可能并不总是考虑个体患者的PIF能力或设备的一致性.
研究的目的:
- 在专业的COPD诊所中确定非最佳PIF和不合适的吸入器设备的患病率.
- 为了确定患者相关的风险因素,以低于最佳的PIF.
- 评估PIF测量对临床决策的影响.
主要方法:
- 一个单一的中心,现实世界的观察性研究,涉及在门诊诊所进行系统的PIF测量.
- 副初级结局集中在低于最佳的PIF和不合适的设备的流行率上.
- 二次结果包括风险因素分析和PIF结果对处方的影响.
主要成果:
- 28%的患者表现出低于最佳的PIF,11.2%使用不适当的设备.
- 低于最佳PIF的风险因素包括女性性别,年龄较大,BMI较低和FEV1.1降低.
- 36.6%的患者使用了不合适设备的吸入器方案或非单个吸入器治疗 (SIT) /非类似设备,促使处方变化.
结论:
- 低于最佳的PIF和不合适的吸入器设备在专业的COPD诊所中很常见.
- 女性性别,降低FEV1和低BMI是低于最佳PIF的关键,可识别的风险因素.
- 在医疗中心测量PIF有效地为吸入器治疗的临床决策提供了信息.
更多相关视频
相关概念视频
Inhaled Medications
237
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237
COPD: Management Using Bronchodilators and Corticosteroids
184
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
184
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.7K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.7K


